Early Real-World First-Line Treatment With Venetoclax Plus HMAs Versus HMA Monotherapy Among Patients With AML in a Predominately US Community Setting

Autor: Gershon, Anda, Ma, Esprit, Xu, Tao, Montez, Melissa, Naqvi, Kiran, Ku, Grace, Cheng, Wendy Wei-Han, Flahavan, Evelyn M., Kota, Vamsi, Greenwald, Daniel R.
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia May 2023 23(5):e222-e231
Databáze: ScienceDirect
Externí odkaz: